Abstract 181: Meta-Analysis of Genome-Wide Association Studies Identifies Two New Susceptibility Loci for Intracerebral Hemorrhage
Background: Intracerebral hemorrhage (ICH) is the stroke subtype with the worst prognosis and has no established acute treatment. ICH is classified as lobar and non-lobar based on the location of the hemorrhage, with genetic variation contributing to risk of both subtypes. We report the first genome wide association study (GWAS) of this condition.
Methods: The discovery phase included GWAS data (Illumina 610 or Affymetrix 6.0) from 6 ICH studies that enrolled subjects of European ancestry in the US and Europe. Cases were classified as lobar or non-lobar ICH based on head CT. ICH-free controls were selected from ambulatory clinics or by random digit dialing. Standard quality controls filters were applied and principal component analysis was used to account for population structure. Unobserved genotypes were inferred by imputation to 1000 genomes references panels. Association testing was carried out using logistic regression, assuming additive effects, and including age, gender and principal components in the model. Meta-analyses were completed using the inverse normal method, weighting by sample size. Replication of signals with p<1x10E-6 was pursued in an independent multi-ethnic study utilizing direct genotyping.
Results: The discovery phase included 1545 cases (664 lobar and 881 non-lobar) and 1481 controls, and tested 5,358,103 SNPs. Two loci were identified: for lobar ICH, an intergenic region located on chromosome 12q21.1 (rs11179580: minor allele frequency [MAF] 0.22, OR 1.54, 95% CI 1.33 - 1.84; p = 6.7x10E-8); and for non-lobar ICH, a region on chromosome 1q22 encompassing the PMF1 and SLC25A44 genes (rs2984613: MAF 0.31, OR 1.45, 95% CI 1.2 - 1.64; p = 8.9x10E-9). Replication included 1256 cases (329 whites, 506 blacks and 421 Hispanics) and 760 controls (237 whites, 346 blacks and 177 Hispanics) and confirmed both loci: 12q21.1 (p = 0.037, meta-analysis p = 2.3x10E-8) and 1q22 (p = 3.0x10E-4, meta-analysis p = 2.2x10E-11).
Conclusions: Two new susceptibility loci for ICH were identified, both showing location-specificity. These results confirm the presence of biological heterogeneity across ICH subtypes and highlight that different genetic risk factors may contribute to the small vessel diseases that underlie each ICH subtype.
Author Disclosures: D. Woo: Research Grant; Significant; NINDS NS 36695. G.J. Falcone: None. W.J. Devan: None. W.M. Brown: None. A. Biffi: None. C.D. Anderson: Research Grant; Significant; American Brain Foundation. R. Deka: Research Grant; Significant; NINDS NS 36695. J.G. Woo: Research Grant; Significant; NIH Grant. L.J. Martin: None. J.M. Jagiella: None. B. Norrving: None. J. Jimenez-Conde: None. A. Urbanik: None. D.L. Tirschwell: None. M. Selim: None. S.L. Silliman: None. B.B. Worrall: Research Grant; Significant; National Human Genome Research Institute, National Institute of Neurological Disorders and Stroke, National Heart, Lung, and Blood Institute. Other; Significant; Associate Editor (Neurology). J.F. Meschia: None. C.S. Kidwell: None. J. Montaner: None. I. Fernandez-Cadenas: None. M. Dichgans: None. S.M. Greenberg: Research Grant; Significant; National Institutes of Health. Consultant/Advisory Board; Significant; Hoffman-Laroche, MRI review committee. P.M. Rothwell: None. A. Lindgren: None. A. Slowik: None. R. Schmidt: None. C.D. Langefeld: None. J. Rosand: Research Grant; Significant; National Institutes of Health, American Heart Association.
- © 2014 by American Heart Association, Inc.